TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction

MLA

Christopher T. Lux, et al. “TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction.” Molecular Therapy: Methods & Clinical Development, vol. 12, no. 175–183, Mar. 2019, pp. 175–83. EBSCOhost, https://doi.org/10.1016/j.omtm.2018.12.008.

APA

Christopher T. Lux, Sowmya Pattabhi, Mason Berger, Cynthia Nourigat, David A. Flowers, Olivier Negre, Olivier Humbert, Julia G. Yang, Calvin Lee, Kyle Jacoby, Irwin Bernstein, Hans-Peter Kiem, Andrew Scharenberg, & David J. Rawlings. (2019). TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction. Molecular Therapy: Methods & Clinical Development, 12(175–183), 175–183. https://doi.org/10.1016/j.omtm.2018.12.008

Chicago

Christopher T. Lux, Sowmya Pattabhi, Mason Berger, Cynthia Nourigat, David A. Flowers, Olivier Negre, Olivier Humbert, et al. 2019. “TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction.” Molecular Therapy: Methods & Clinical Development 12 (175–183): 175–83. doi:10.1016/j.omtm.2018.12.008.